In an attempt to discover novel determinants of HCV-related liver fibrosis progression, a joint French/Swiss study group identified an endoglin variant, Thr5Met, the frequency of which was higher among HCV/fibrosis patients than among HCV/controls [200]. The gene discussed is ENG; the disease is Hepatic fibrosis.